SAN JOSE, Calif., Oct. 5, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System® (“iFuse”), a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced it has submitted INSITE (Investigation of Sacroiliac Fusion Treatment – NCT01681004) 2-year randomized controlled trial (RCT) data to Yale University’s Open […]